NEWS

Exclusive License Agreement with The University of Hong Kong Technology Transfer Office (HKU TTO) for the patent for develop, make and sell the licensed products related to the prevention and treatment of infection of SARS-CoV-2

Exclusive License Agreement with HKU TTO for the patent for develop, make and sell the licensed products related to the Antibody against PD-1 Isoforms for cancer and inflammatory diseases

Hong Kong Scientists Make Potential HIV Treatment Breakthrough

Learn More

Exclusive License Agreement with HKU TTO for the patent of PD-1-based DNA vaccine for prevention and treatment of HIV

Study sheds light on cancer prevention and immunotherapy

Learn More

港大研發抗腫瘤疫苗方法

Learn More